Quantcast

Latest The City of London Migraine Clinic Stories

2011-09-02 01:00:00

Dr. Kenneth Reed will discuss a migraine treatment known as the StimPath procedure at a free migraine seminar on Sept. 1, 2011 in Atlanta. Dallas, TX (PRWEB) September 01, 2011 Dr. Kenneth Reedâ”renowned migraine specialist and innovator of the StimPath procedure, a novel migraine treatment that offers relief to people who suffer from debilitating migraine painâ”will host a free seminar in Atlanta at 6 p.m. on Thursday, September 1, 2011, Ascendant...

2011-08-15 00:00:29

Migraine treatment known as the StimPath procedure was featured on Top Docs as a treatment to help individuals who suffer from debilitating headache pain. Dallas, TX (PRWEB) August 13, 2011 Ascendant Neuro announced that the StimPath procedure, an innovative migraine treatment for people who suffer from debilitating headache pain, was featured on the July 31 edition of Top Docs of DFW, the popular Sunday morning program on KDAF-TV, Channel 33. "What we've developed is a procedure using an...

2011-06-07 07:00:00

CHICAGO, June 7, 2011 /PRNewswire/ -- The National Headache Foundation (NHF) announced today that it is partnering with CBS Los Angeles reporter Serene Branson to launch "More Than Just a Headache," a new education campaign to raise awareness of the prevalence and impact of migraines. The campaign helps to kick off June as National Migraine Awareness Month (NMAM) and educate the public on the personal and societal costs of migraines, while also providing resources for the 30 million...

2011-06-06 20:08:10

Migraine specialists attending the American Headache Society (AHS) science meeting here this weekend say they believe that more government money for migraine research holds the most promise for winning the battle against the disease. When asked to rank four areas of research need, 40 % say an increase in public funds is more important even than understanding basic aspects of the disease -- more than early intervention in a migraine attack (28%), migraine genetics (25%), or the role of the...

2011-06-06 07:30:00

SAN DIEGO, June 6, 2011 /PRNewswire/ -- Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year(1). In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient's "treatment toolbox" to address specific types of migraine...

2011-04-21 07:05:00

CHICAGO and RESEARCH TRIANGLE PARK, N.C., April 21, 2011 /PRNewswire/ -- Could migraine patients be doing more to get the most out of their medical visits? According to a new national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline, the answer is yes. For the nearly 30 million migraine sufferers in the U.S., including six million treating with prescription medication, these survey results may have important implications. To view the multimedia assets...

2011-04-07 06:00:00

MOUNTAIN VIEW, Calif., April 7, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the publication of results from the Phase 3 FREEDOM-301 study of LEVADEX(TM) orally inhaled migraine drug in the peer-reviewed journal 'Headache.' The manuscript, titled MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine, has been posted online and will appear in the April edition, Volume 51, Issue 4 of Headache: The Journal of Head and...

2011-03-01 10:17:00

PHILADELPHIA, March 1, 2011 /PRNewswire/ -- Health Union, LLC announced today the launch of its first website, Migraine.com (http://migraine.com). This independent site will feature robust, physician-reviewed information on the clinical and social aspects of Migraine disease, as well as numerous interactive tools to help patients and caregivers better understand and manage the condition. Over time, the site will leverage its extensive community platform where patients, caregivers, and...

157604f1b6132f281b186f69c4a270b2
2011-02-03 09:21:56

5 years later, nearly 90 percent of patients have at least partial relief of migraine headaches Surgery to "deactivate" migraine headaches produces lasting good results, with nearly 90 percent of patients having at least partial relief at five years' follow-up, reports a study in the February issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). In about 30 percent of patients, migraine headaches were...

2010-12-21 07:00:00

MOUNTAIN VIEW, Calif., Dec. 21, 2010 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced completion of the LEVADEX(TM) open-label safety trial. The Company has now completed the final trial necessary to support a New Drug Application (NDA) for LEVADEX and plans to submit an NDA in the first half of 2011. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 clinical development for the acute treatment of migraine. "We are pleased...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related